139 related articles for article (PubMed ID: 28791373)
1. Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.
Cheng DD; Li SJ; Zhu B; Yuan T; Yang QC; Fan CY
Oncol Rep; 2017 Oct; 38(4):2116-2122. PubMed ID: 28791373
[TBL] [Abstract][Full Text] [Related]
2. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
[TBL] [Abstract][Full Text] [Related]
3. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
Liu G; Yuan D; Sun P; Liu W; Wu PF; Liu H; Yu GY
J Cell Physiol; 2018 Nov; 233(11):8639-8647. PubMed ID: 29904919
[TBL] [Abstract][Full Text] [Related]
4. BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
Gao H; Yu G; Zhang X; Yu S; Sun Y; Li Y
J Cell Mol Med; 2019 Jun; 23(6):3905-3915. PubMed ID: 30932331
[TBL] [Abstract][Full Text] [Related]
5. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
9. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
10. Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma.
Wang G; Zhang T; Sun W; Wang H; Yin F; Wang Z; Zuo D; Sun M; Zhou Z; Lin B; Xu J; Hua Y; Li H; Cai Z
Free Radic Biol Med; 2017 May; 106():24-37. PubMed ID: 28188923
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.
Zhang D; Wang S; Chen J; Liu H; Lu J; Jiang H; Huang A; Chen Y
Int J Oncol; 2017 May; 50(5):1513-1530. PubMed ID: 28339091
[TBL] [Abstract][Full Text] [Related]
12. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.
Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q
Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098
[TBL] [Abstract][Full Text] [Related]
13. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
14. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.
Huang L; Chen S; Fan H; Ai F; Sheng W
J Cell Physiol; 2020 May; 235(5):4834-4842. PubMed ID: 31643092
[TBL] [Abstract][Full Text] [Related]
15. BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis.
Agarwal S; Afaq F; Bajpai P; Behring M; Kim HG; Varambally A; Chandrashekar DS; Peter S; Diffalha SA; Khushman M; Seeber A; Varambally S; Manne U
Mol Cancer Res; 2023 Jul; 21(7):698-712. PubMed ID: 37067340
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway.
Cheng DD; Zhu B; Li SJ; Yuan T; Yang QC; Fan CY
J Cancer; 2017; 8(14):2720-2728. PubMed ID: 28928861
[No Abstract] [Full Text] [Related]
17. Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway.
Ren C; Pan R; Hou L; Wu H; Sun J; Zhang W; Tian X; Chen H
Mol Med Rep; 2020 Apr; 21(4):1739-1748. PubMed ID: 32319617
[TBL] [Abstract][Full Text] [Related]
18. SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway.
Wang Y; Wang W; Qiu E
Biomed Pharmacother; 2017 Nov; 95():564-570. PubMed ID: 28869894
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]